Eli Lilly (NYSE:LLY) Receives Overweight Rating from Cantor Fitzgerald with Increased Price Target
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameEli Lilly & Company
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









